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The objective of this study was to formulate an oral sustained release delivery system of sodium 
diclofenac(DS) based on sodium alginate (SA) as a hydrophilic carrier in combination with chitosan (CH) 
and sodium carboxymethyl cellulose (SCMC) as drug release modifiers to overcome the drug-related 
adverse effects and to improve bioavailability. Microspheres of DS were prepared using an easy method 
of ionotropic gelation. The prepared beads were evaluated for mean particle size, entrapment efficiency, 
swelling capacity, erosion and in-vitro drug release. They were also subjected to various studies such as 
Fourier Transform Infra-Red Spectroscopy (FTIR) for drug polymer compatibility, Scanning Electron 
Microscopy for surface morphology, X-ray Powder Diffraction Analysis (XRD) and Differential Scanning 
Calorimetric Analysis (DSC) to determine the physical state of the drug in the beads. The addition of 
SCMC during the preparation of polymeric beads resulted in lower drug loading and prolonged release 
of the DS. The release profile of batches F5 and F6 showed a maximum drug release of 96.97 ± 0.356% 
after 8 h, in which drug polymer ratio was decreased. The microspheres of sodium diclofenac with the 
polymers were formulated successfully. Analysis of the release profiles showed that the data corresponds 
to the diffusion-controlled mechanism as suggested by Higuchi.
Uniterms: Alginate beads/preparation. Alginate beads/evaluation. Drugs/sustained release. 
Interpenetrating network. Sodium diclofenac/microsphere/sustained release. Ionotropic gelation.
O objetivo deste estudo foi elaborar um sistema de entrega de oral de liberação sustentada de diclofenaco 
sódico (DS) com base em alginato de sódio (SA), como um transportador hidrofílico em combinação com 
quitosana (CH) e carboximetilcelulose de sódio (SCMC) como modificadores de liberação de fármaco 
para diminuir os efeitos adversos e melhorar a biodisponibilidade. Prepararam-se microesferas de DS 
usando um método fácil de geleificação ionotrópica. Avaliaram-se os grânulos preparados quanto ao 
tamanho médio de partícula, eficiência de compressão, inchaço in vitro, erosão e capacidade de liberação 
de fármacos. Estes tammbém foram submetidos a vários estudos, como espectrometria no infravermelho 
com transformada de Fourier (FTIR) para compatibilidade de fármaco e polímero, microscopia eletrônica 
de varredura para morfologia de superfície, análise de difração de raios-X (XRD) do pós e análise 
calorimétrica diferencial de varredura (DSC) para determinar o estado físico do fármaco nos grânulos. A 
adição de SCMC durante a preparação de grânulos do polímero resultou em fármacos com menor carga 
de fármaco e liberação prolongada do DS. O perfil de liberação dos lotes F5 e F6 apresentou máximo 
de fármaco liberado de 96,97±0,356% após 8 h após o que a proporção do fármaco no polímero foi 
diminuída. As microesferas de diclofenaco de sódio com os polímeros foram formuladas com sucesso. A 
análise dos perfis de liberação mostrou que os dados correspondem ao mecanismo de difusão controlada, 
como sugerido por Higuchi.
Unitermos: Grânulos de alginato/preparação. Grânulos de alginato/avaliação. Fármacos/liberação 
sustentada. Rede de interpenetração. Diclofenaco de sódio/microesferas/liberação sustentada. Geleificação 
ionotrópica.
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INTRODUCTION
Oral drug delivery using biodegradable natural 
polymeric particulate systems are becoming a clinical 
reality with many benefits for patients. The versatility 
of polymeric materials allows the fabrication of the drug 
delivery devices with a desirable degree of swelling and 
consequently of drug release (Basu, Rajendran et al., 2008). 
Alginate has been used by many researchers for controlled 
delivery of incorporated materials (Girhepunje et al., 2010; 
Ouwerx et al., 1998; Bajpai, Sharma, 2004). Alginate is a 
naturally occurring polysaccharide obtained from marine 
brown algae. It is composed of linear copolymers of 1, 
4-linked β-D mannuronic acid and α-L glucuronic acid. It 
gels in the presence of a divalent cation such as calcium. 
Microspheres produced using alginate have been used for 
the encapsulation of a wide variety of bioactive materials, 
proteins, enzymes, micronutrients, antibodies etc. (Griffith 
et al., 2000; Rasmussen et al., 2003; Bodmier, Paeratakul, 
1989). The bio-adhesive nature of alginate with mucosal 
membrane helps to achieve intimate contact between 
intestinal mucosa and lower-sized microspheres (Sezer, 
Akbuga, 1999; Fernadez-Hervas et al., 1998; Gonzalez-
Rodriguez et al., 2002). Chitosan is a cationic linear 
polysaccharide. It is non-toxic and biodegradable. It is a 
β(1-4) linked biopolymer composed of 2-amino-2-deoxy-
β-D-glucan combined by glycosidic linkages. Chitosan 
consists of a large number of amine groups which allow 
interaction between chitosan and many other substances. 
Chitosan exhibits unique functional, nutritional, and 
biomedical properties (Remuńår-López et al., 1998; Kim 
et al., 2003; Torre et al., 2003). Chitosan has been used 
for many biomedical and pharmaceutical applications 
to improve drug delivery as well as for controlled 
delivery (Sanil et al., 2007; Sipahigil et al., 2006). In 
the case of drug delivery applications, chitosan has been 
employed for preparation of drug-loaded microcapsules/
microspheres and used to provide controlled drug release 
and improve bioavailability of drugs (Lee et al., 1996). 
Sodium CMC (SCMC) was combined in formulation 
to improve viscosity and for the additive effect of the 
mucoadhesive property (Prajapati et al., 2012; Semalty 
et al., 2008). A concentration range from 0.1 to 0.5% w/v 
SCMC formed a clear and stable formulation. SCMC 
was selected as a polymer over other polymers due to 
its better mucoadhesive capacity in comparison to that 
of other mucoadhesive polymers such as poly (acrylic 
acid) (PAA) and polycarbophils. Polyelectrolyte complex 
(PEC) in the form of beads or microspheres formed 
by cationic polymer(s) and anionic polymer(s) could 
further enhance the controlled or prolonged release of 
the drug. Examples of PEC for controlling drug release 
include alginate/chitosan (Parfitt, Marindale, 1996), 
chitosan-cellulose multicore microparticles (Sanil et 
al.,2007), chitosan-coated pectin (Sipahigil et al., 2006), 
chitosan/poly(acrylic acid) complexes (Sezer, Akbuga, 
1999), poly(vinylalcohol)/sodium alginate blend beads 
(Gonzålez-Rodriguez et al., 2002), and poly(methacrylic 
acid-g- ethylene glycol) particles (Lee et al., 1996). The 
non-steroidal anti-inflammatory drug, sodium diclofenac 
is a good candidate for the development of oral sustained 
release formulations. It is administered as conventional 
tablets/capsules for the treatment of rheumatoid arthritis, 
osteoarthritis with a dose of 75-150mg divided for 
administration 2-3 times a day (Parfitt et al., 1996). An 
adverse gastrointestinal reaction has been observed and 
due to a short biological half-life it requires multiple 
dosing. This leads to fluctuation in the drug-blood levels 
and dose-related adverse effects, and multiple dosing also 
fails to release the drug in the desired amount at the desired 
rate which often results in poor patient compliance and 
inefficient therapy (Peter et al., 1997).
The aim of the present study was to a develop 
an oral sustained-release delivery system consisting 
of beads of sodium diclofenac using sodium alginate 
as a hydrophilic carrier in combination with chitosan 
and sodium carboxymethyl cellulose as drug release 
modifiers in various proportions to overcome the drug-
related adverse effect and to improve bioavailability. 
In the proposed method – ionotropic gelation, which 
involves the addition of a mixture of drug and polymer(s) 
dispersion into aqueous solution of calcium chloride 
solution, gelation occurs instantaneously resulting in 
the formation of spherical microscale-sized beads with 
narrow particle size, low porosity and an optimum 
sustained-release profile in various physiological 
gastrointestinal conditions (Edith et al., 1999; Manjanua 
et al., 2009; Martisen et al., 1989).
MATERIAL AND METHOD
Material
Sodium diclofenac (DS) IP (gift sample from Blue 
Cross Laboratories Limited, Mumbai); Sodium alginate 
(SA) (Sigma, USA) - Medium viscosity grade (250 cps- 
2% w/v of solution in water); Chitosan (CH) (85% degree 
of deacetylation, molecular weight more than 103 kD) from 
India sea foods, Cochin, India); Sodium carboxymethyl 
cellulose (SCMC)(Loba Chemie, Mumbai, India); 
Calcium chloride dehydrate (E.Merck, India). All other 
reagents were of analytical grade.
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Preparation of polyelectrolyte complex 
microspheres
The microspheres were prepared using various 
concentrations of different polymers including sodium 
alginate, chitosan and sodium carboxymethylcellulose 
(Table I). The gelation medium was prepared by dissolving 
Calcium chloride in distilled water at the concentration of 
2% (w/v). The homogenous mixture of various polymers 
and drug solution was added drop-wise into the gelation 
medium using a 10 mL hypodermic syringe through a # 
21 needle under constant stirring at room temperature. 
The beads thus formed were cured in the gelation medium 
for 4 h and then taken out. The beads thus obtained were 
immediately put in the sodium alginate solution (0.1% w/v) 
for 5 min and then transferred into calcium chloride solution 
(1% w/v) for 30 min. Finally the beads were taken out, 
washed with distilled water and then allowed to dry at 30 oC 
in a dust-free chamber until they attained constant weight.
Characterization of microspheres
Particle size analysis and morphological studies
The particle size determination of sodium alginate 
beads was carried out using an optical microscope 
along with ocular and stage micrometer. At least 200 
microspheres were analyzed for each preparation and 
the mean diameter calculated. The surface morphology 
and appearance of the microspheres were examined by a 
scanning electron microscopy using a JEOL JSM-6360 
model scanning electron microscope (SEM). The beads 
were mounted on an appropriate stub and then coated with 
carbon and gold (100 and 50 Ǻ thickness, respectively) 
sputter module in a vacuum evaporator under an argon 
atmosphere. The coated samples were then observed under 
a scanning electron microscope operated at 15KV. Each 
experiment was done in triplicate.
Determination of entrapment efficiency
For the determination of drug loading capacity, 
100 mg of sodium alginate bead formulation was taken in 
a 100 mL volumetric flask and phosphate buffer (pH7.4) 
was added up to volume and kept overnight. The mixture 
was then filtered and absorbance measured at 276 nm 
using a Cary 50 Bio UV-Visible spectrophotometer. Drug 
content was computed using a calibration curve prepared 
using dilutions with concentrations of 1-6 µg/mL of DS. 
The drug loading capacity of the beads was then computed 
according to the following equation (Marsh et al., 1967):
Experimental drug loading = L/L0 x 100
where, L is the actual drug content and L0 is the weighed 
quantity of beads
Entrapment efficiency was calculated using the 
formula given below:
Entrapment efficiency (%) = EL/TL x 100
where, EL is the experimental drug loading and TL is 
the theoretical amount of drug in beads calculated from 
the quantity added during the fabrication process. Each 
experiment was done in triplicate.
Swelling Study
Beads were placed in a watch glass and phosphate 
TABLE I - Formulation design
Sl.no
sodium 
alginate(SA) 
(% w/v)
chitosan 
(% w/v)
sodium 
carboxymethyl 
cellulose (SCMC) 
(% w/v)
calcium chloride 
(% w/v)
Drug: sodium 
alginate
Gelation time
(h)
F1 3 0 0 2 1:4 4
F2 3 0.75 0.5 2 1:4 4
F3 3 0.5 1 2 1:4 4
F4 3 0 0.5 2 1:4 1
F5 3 0.5 0 2 1:4 1
F6 3 0.5 0.5 2 1:3 4
F7 4 0.5 0.5 2 1:2 4
F8 3 0.75 1 3 1:4 4
F9 3 0.5 0.5 5 1:4 4
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buffer (pH 7.4) was added. Swelling rate was determined 
by measuring the diameter of several particles periodically. 
Measurements were made by the sieving method using 
USP standard sieves (Peter et al., 1997). Each experiment 
was done in triplicate.
Erosion studies
The dried beads were weighed and placed in 
dissolution baskets (Anal et al., 2003). These were then 
subjected to dissolution in phosphate buffer (pH 7.4). The 
rpm was set at 50. At 1-hr intervals, the beads were taken 
out from the basket and dried in an oven at 50 °C. When 
all water was removed, the weight of beads was taken. 
After this, the beads were placed in the basket again. This 
process was continued for 6 hr. Each experiment was done 
in triplicate.
These results are given in percentage of bead 
weight loss (mean ± SD.; n=3) using the following 
formula:
wo = Initial weight of bead, w1 = weight after drying.
In-vitro drug release studies
In vitro drug release studies were carried out in 
triplicate using a USP XX II Dissolution test Apparatus 
(model TDP-06P, Electro Lab, Mumbai, India) at a speed 
of 50 rpm and the temperature maintained at 37 ± 0.5 oC. 
The beads of each formulation were placed in enzyme-free 
simulated gastric fluid (900 mL, 0.1 N HCl pH 1.2) for the 
first 2 h then the beads were filtered and again placed in 
intestinal fluid (900 mL, phosphate buffer solution, pH 7.4) 
for 7 h. A 5 mL aliquot of dissolution fluid was withdrawn 
from the dissolution medium at predetermined time 
intervals and replaced immediately with the same volume 
of fresh media. The aliquots were then analyzed for drug 
content using a Cary 50 Bio UV-Visible spectrophotometer 
at 276 nm.
Kinetic modeling of drug release
The dissolution of all the formulations was carried 
out. The dissolution profile of all the batches was fitted to 
zero-order, first-order, Higuchi and Korsmeyer-Peppas to 
ascertain the kinetic modeling of drug release. The reading 
was then processed for dissolution data using PCP Disso 
v3 software. Lag time was considered and all the data was 
processed for fitting of the models.
FTIR Spectroscopic Analysis
The FT-IR analyses of pure drug (DS), polymers, 
blank and drug loaded beads were performed using KBr 
pellets on a Shimadzu FTIR instrument (JASCO, model 
4200, Japan), compressed in a hydraulic press at 10 tons 
for 30 seconds.
Differential Scanning Calorimetric Analysis
The possibility of any interaction between sodium 
diclofenac and sodium alginate, chitosan, and sodium 
carboxymethyl cellulose during the formulation was 
assessed by carrying out thermal analysis on sodium 
alginate, sodium carboxymethyl cellulose, chitosan, pure 
drug (sodium diclofenac), empty beads and drug-loaded 
beads (Mettler TA 4000). The thermograms of the samples 
were obtained at a scanning rate 10 ºC/min conducted over 
a temperature range of 30-300 oC.
X-ray Powder Diffraction Analysis
The X-ray diffraction patterns of pure Diclofenac 
sodium, polymers and drug-loaded beads were done and 
the diffraction pattern of pure drug was compared with 
the drug-loaded beads. The powder form of samples 
was exposed to cu radiation (30 KV*15 mA) in a wide 
angle X-ray diffractometer (Miniflex goniometer). The 
instrument was operated in the continuous mode, in 
increments of 0.010o, 2 Theta.
RESULT AND DISCUSSION
Particle size and morphological characteristics
Mean particle size of the different DS-loaded bead 
formulations were in the range of 438.29 ± 0.294 µm to 
1190.11±0.944 µm shown in (Table II). It was observed 
that the addition of polymers, SCMC and chitosan resulted 
in an increase in the particle size as the amount of drug 
is increased (F6, F7). The particle size of batch F2 was 
smaller than the particle size of F1 due to addition of sodium 
carboxymethyl cellulose in the formulation, as alginate and 
chitosan take longer for the cross-linking and SCMC is a 
more water-soluble polymer than the other two and leaches 
out from the formulation, although IR spectra revealed its 
presence in the formulation. (Figure 1 a, b, c) shows the 
scanning electron photomicrograph of the surface of DS-
loaded alginate, SCMC and chitosan microspheres.
The results indicate a proportionate increase in the 
particle size of beads with increasing amount of drug 
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FIGURE 1 (a) -SEM photograph of beads before dissolution 
(F3).
FIGURE 1 (b) - SEM photograph of beads after dissolution (F3).
FIGURE 1 (c) -SEM photograph of only alginate beads (F1).
ratio in the formulation (F6, F7). This could be attributed 
to an increase in diameter by accumulation of a greater 
percentage of the drug. On the other hand, the mean 
particle size of beads was found to decrease with an 
increase in calcium chloride concentration (F8& F9). It has 
been stated that when a drop of alginate solution comes in 
contact with calcium ions, gelation occurs instantaneously. 
As Ca+2 ions penetrate into the interior of droplets, water 
molecules are squeezed out from their interior resulting 
in contraction of beads (Miura et al., 1999).The increase 
in the size of the beads was clearly evident with increase 
in the concentration of chitosan in the gelation medium 
(Anal et al., 2005). Decrease in curing time resulted in a 
decrease in the particle size (F4, F5).
The SEM photograph of the drug-loaded beads 
shows that the drug is dispersed in the polymeric matrix 
as the surface is smooth with absence of any lumps, 
TABLE II - Properties and in-vitro drug release of polymeric alginate beads
Formulation code Entrapment efficiency 
(%)
Particle size 
(µm)
Cumulative percentage 
release pH 1.2(%) (*)
Cumulative percentage 
release pH 7.4(%) (#)
F1 71.66±1.28 1036.45±1.143 14.59±0.179 92.44±0.269
F2 96.27±3.68 573.46±0.74 06.53±0.844 93.73±0.761
F3 80.07±4.35 610.34±0.418 07.33±0.926 91.43±0.799
F4 45.58±2.17 438.29±0.294 10.14±0.434 84.56±0.564
F5 51.67±3.27 557.78±1.13 16.01±0.546 96.97±0.356
F6 92.39±03.4 1190.11±0.944 04.79±0.254 96.97±0.776
F7 95.34±0.94 948.79±0.231 08.49±0.566 94.18±0.963
F8 87.13±1.87 770.39±1.048 10.39±0.312 93.90±0.863
F9 74.39±3.56 839.28±1.040 13.45±0.312 97.99±0.723
A. K. Saha, S. D. Ray878
which confirms that this system is a polymeric matrix 
system. The SEM photographs presented in (Figure 1 
a, b) also show difference in the surface morphology 
of the prepared beads before and after the completion 
of the in-vitro dissolution study. The surface of beads 
after dissolution was rougher than before dissolution. 
The SEM photographs depicted in (Figure 1 c) indicate 
greater smoothness in the surface of prepared beads due 
to the addition of polymers, chitosan and sodium CMC. 
They also show that the drug is dispersed in polymeric 
matrix even in the case of beads prepared with different 
polymers in combination.
Entrapment Efficiency
Entrapment efficiency was found to be in the range 
of 45.58±2.17 to 96.27±3.68, respectively, as shown in 
(Table II). The variation in concentration of polymers had 
a profound effect on the loading of sodium diclofenacin 
alginate beads. The drug loading increases with the 
addition, as well as with increase in the concentration, 
of sodium alginate and chitosan (F2, F7). However, the 
drug-loading capacity decreased in the case of F4 and 
F5 and this may be due to less gelation time given after 
the formation of beads. Increase in the concentration of 
calcium chloride decreases drug loading (F8 & F9); this 
may be attributed to increased porosity of the beads (Miura 
et al., 1999).The drug loading increased with increase in 
drug-polymer (alginate) ratio.
The variations in concentration of polymers had an 
effect on entrapment efficiency of DS in alginate beads. In 
the absence of chitosan, entrapment of the drug is slightly 
decreased. This may be due to insufficient cross-linking 
and large pore size permitting the drug to diffuse out 
during and after gelation (Marsh et al., 1967). Addition of 
0.5%-0.75% of chitosan to the gelation medium resulted 
in an increase in entrapment. The increase in entrapment 
efficiency may also be attributed to greater availability of 
active calcium binding sites in the polymeric chains and 
consequent greater degree of cross-linking as the amount 
of sodium alginate increases. Since the solubility of DS 
is slightly higher in calcium chloride solution than in 
distilled water, prolonged exposure caused greater loss 
of drug in the curing medium. Increase in the alginate 
concentration reduced loss of drug in the curing medium 
due to formation of a dense matrix structure.
Swelling Capacity and erosion study
The swelling and erosion profiles of F1 as only SA 
beads and F2, F3, F4 as modified SA beads with different 
proportions of CH and SCMC are given in (Figure 2 and 
figure 3).
When immersed in distilled water, the SA beads 
begin immediately to swell, recovering their initial 
production spherical shape. The % diameter of SA beads 
is increased with the increased proportion of SCMC and 
CH. The swelling rate of beads was obtained from the 
slope of the relationship between the % diameter and 
the square root of time. This relationship provided good 
linearity with R2 of more than 0.98 when analyzed by 
linear regression analysis in Table III. The swelling rate 
of beads tended to increase as the concentration of SCMC 
increased. Using phosphate buffer, the swelling rate of 
the beads cannot be estimated because of quick erosion. 
Water uptake increases with time, leading to an initial loss 
of spherical shape within 1 h. On the other hand, cross-
linked SA beads exhibit an initial faster diameter increase, 
FIGURE 2 - Bead diameter variation (expressed as percentage 
of diameter increase) after contact with phosphate buffer pH 
7.4(mean± S.D.; n=3): of F1 only SA beads; F2, F3, F4 are 
SCMC and CH modified SA beads.
FIGURE 3 -Bead erosion in phosphate buffer pH 7.4 (mean ± 
S.D.; n=3): of F1 only SA beads; F2, F3, F4 are SCMC and CH 
modified SA beads.
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TABLE III - Swelling rates of Sodium alginate and modified SA 
beads
Formulation Swelling rate (cm/s)
F1 09.09 (0.98)
F2 19.03 (0.99)
F3 19.20 (0.98)
F4 19.71 (0.98)
which slows down after 15 min while keeping their shape. 
Incorporation of SCMC and CH promoted the swelling 
properties because both provided higher water uptake 
capacity than SA.
In the erosion tests performed in phosphate buffer 
pH 7.4, both types of beads exhibited an initial increase 
in volume. The SA beads started to erode significantly at 
30-45 min and their spherical form vanished after 120-
180 min, whereas the cross-linked formulations kept their 
shape throughout the test (80% integrity after 5hr). This 
feature was also observed during the entire drug release 
tests and probably is the main cause of the diclofenac 
prolonged release profile from beads.
In vitro Drug Release studies 
The release profiles of DS in the enzyme-free 
gastric fluid (SGF) followed by enzyme-free intestinal 
fluid from the alginate beads are shown in (Figure 4, 5 
and 6). The drug release from alginate beads depends on 
the penetration of the dissolution of medium into beads, 
the eventual swelling and diffusion through the swollen 
matrix, dissolution of the alginate matrix and subsequent 
dissolution of the leached out drug. In SGF, the beads 
released 4-16% DS in the first 2h and after that the rest of 
the drug in the SIF which continues up to 9h where 84-97% 
of the drug was released, as shown in Table II. The burst 
effect was not found during the release of the drug, which 
may be due to its water insoluble nature.
The effect of the different concentrations of 
polymers used (SA- 3% & 4% w/v, SCMC- 0.5% & 1.% 
w/v, chitosan- 0.5% & 0.75% w/v) was also observed. 
The release of drug from the polymeric matrix decreased 
due to addition of polymer. Polymers such as sodium 
alginate, sodium carboxymethyl cellulose and chitosan 
entrapped the drug more tightly in the polymeric matrix 
(Martisen et al., 1989). Concentration of polymers, sodium 
alginate, sodium carboxymethyl cellulose and chitosan, 
when increased, lead to slower drug release. When the 
concentration of sodium alginate increases, cumulative 
release decreases from 96.97 ± 0.776% to 94.18 ± 0.963% 
FIGURE 4 -Comparative results of in vitro release profile of 
different proportions of SA, CH, and SCMC beads of sodium 
diclofenacin phosphate buffer pH 7.4.
FIGURE 5 - Comparative results of in vitro release profile of 
different proportions of SA, CH, and SCMC beads of sodium 
diclofenacin phosphate buffer pH 7.4.
FIGURE 6 - Comparative results of in vitro release profile of 
different proportions of SA, CH, and SCMC beads of sodium 
diclofenacin hydrochloric acid buffer pH 0.1.
(F6, F7). In the case of the other two polymers, these also 
showed the same result. The cumulative release of drug 
after 8 h decreased from 96.97±0.356% to 84.56 ± 0.564% 
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(F5, F4) and from 96.97 ± 0.776% to 94.18 ± 0.963% 
(F6, F7) as the concentration of Sodium carboxymethyl 
cellulose and chitosan increased, respectively. The 
decrease in the rate of drug release is much slower when 
the concentrations of both the polymers increase than 
with increase in the concentration of only one polymer, 
as exemplified by the release profile of batch F4 where 
the maximum drug release was 84.56 ± 0.564% after 8 h.
Release Kinetics for DS-loaded beads
To determine the mechanism of drug release from 
these formulations, the data were treated with various 
models such as zero-order, first-order, Higuchi, and 
Korsmeyer–Peppas. Different results were obtained and 
the models which best fit the drug release from different 
formulations are shown in (Table IV). From the linear 
regression analysis, the coefficient of determination (r2 
was in range 0.9090 to 0.9967) indicated that the data 
corresponds to a diffusion-controlled mechanism, as 
suggested by Higuchi (Anal et al., 2005).
FT-IR Spectroscopic Analysis
FT-IR of DS showed that the principle IR peak 
at 1284 cm-1 resulted from C-N stretching and peaks 
1504 cm-1 and 1576 cm-1 resulted from C=C stretching and 
C=O stretching of carboxylate group, respectively (Figure 
7 a,b,c,d,e). The IR peaks of DS-loaded SA-SCMC-CH 
beads displayed a combination of unshifted principle 
peaks of drug.
In the FT-IR spectrum of sodium alginate powder, 
the various distinct peaks of alginate evident are those of 
the hydroxyl group at 3429 cm-1, carbonyl at 1609 cm-1 
and carboxyl and carboxylate groups between 1000 
and1400 cm-1. The absorption band around 2880, 1656, 
1421 and 1080 cm-1 corresponds to the stretching of 
–CH, COO-, -CH and C-O-C, respectively. In the FT-IR 
spectrum of the drug-loaded beads/formulation, the band 
2880 cm-1, which corresponds to pure chitosan, was 
TABLE IV -Correlation co-efficient of different kinetics models for drug-loaded beads (Drug release studies pH 7.4)
Formulation code Zero order r2
First order 
r2
Higuchi 
r2
Peppas-Korsmeyer 
r2
F1 0.7649 0.9856 0.9892 0.5387
F2 0.6819 0.9907 0.9760 0.5183
F3 0.8144 0.9898 0.9755 0.5919
F4 0.5184 0.9669 0.9349 0.4792
F5 0.7871 0.9901 0.9853 0.5449
F6 0.9051 0.9926 0.9853 0.6146
F7 0.5148 0.9969 0.9712 0.4792
F8 0.8394 0.9962 0.9850 0.5794
F9 0.8771 0.9290 0.9874 0.5737
FIGURE 7 (a) - FTIR Spectroscopic analysis of pure sodium diclofenac.
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FIGURE 7 (b) - FTIR Spectroscopic analysis of sodium alginate alone.
FIGURE 7 (c) - FTIR Spectroscopic analysis of sodium carboxymethyl cellulose.
FIGURE 7 (d) -FTIR Spectroscopic analysis of chitosan.
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shifted to 3070 cm-1(F2)/2889 cm-1 (F2 blank) indicating 
the confirmation of complex formation between chitosan 
and sodium alginate. It can be concluded that interactions 
between polymers which formed the matrix and drug 
did not occur during the preparation of the drug-loaded 
beads.
Differential scanning colorimetric studies
The comparative DSC thermograms of DS, SA, 
CH, SCMC, blank and drug-loaded beads are given 
in (Figure 8 a,b,c,d,e). DSC tracings of pure DS show 
an exothermic peak at 275.28ºC which corresponds 
to its melting point. The DSC curve of empty beads 
is different from the polymer (SA), indicating the 
confirmation of interaction between SA and Calcium 
ions (Sah et al., 1994). Sodium alginate decomposed 
at about 240 ºC with an exotherm. The peak of the drug 
did not appear in the thermograms of beads containing 
DS. Therefore, the absence of the exothermic peak of 
DS at around 275 ºC in the DSC thermogram of the 
drug-loaded beads suggests that the drug existed in 
an amorphous state as a molecular dispersion in the 
polymeric matrix. In the beads containing drug, there 
was no characteristic exothermic peak observed except 
for one exothermic peak in the 169-200 ºC range which 
may be due to shifting of the peak of SA from its original 
position in the DSC thermogram of the polymer alone. 
This may also indicate that sodium alginate interacts 
with the other polymers and forms a homogeneous 
dispersion.
FIGURE 7 (e) -FTIR Spectroscopic analysis of formulation F2.
FIGURE 8 (a) - Differential Scanning calorimetric analysis of pure drug sodium.
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FIGURE 8 (d) - Differential scanning calorimetric analysis of chitosan.
FIGURE 8 (b) - Differential Scanning calorimetric analysis of sodium alginate alone.
FIGURE 8 (c) -Differential scanning calorimetric analysis of sodium carboxymethyl cellulose.
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FIGURE 8 (e) - Differential scanning calorimetric analysis of formulation F2.
X-Ray diffraction study
In order to confirm the physical state of the drug 
in the beads, X-ray diffraction studies of the pure drug, 
polymers, empty beads and drug-containing beads were 
carried out and the diffractograms shown in (Figure 9 
a, b, c, d, e). From the X-ray diffraction data of drug-
loaded beads, it was seen that no crystalline state of drug 
was detected in drug-loaded beads. This means that the 
drug was not present in the crystalline form in the bead 
matrix, but in an amorphous state. This clearly indicates 
FIGURE 9 (a) - X-ray diffraction analysis of pure drug diclofenac sodium.
that changes in the crystalline state of the drug occurred 
during the preparation of beads by this ionotropic gelation 
method.
CONCLUSION
This study showed that drug-loading and release 
characteristics of DS-loaded alginate beads, alginate-
chitosan beads, and alginate-chitosan-SCMC beads 
are dependent on the presence of a polyelectrolyte 
complex between alginate and chitosan; calcium chloride 
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FIGURE 9 (b) - X-ray diffraction analysis of sodium alginate alone.
FIGURE 9 (c) -X-ray diffraction analysis of sodium carboxymethyl cellulose.
concentration in the gelation medium, drug to polymer 
ratio, and pH of the dissolution medium. The FT-IR 
studies revealed that no drug polymer interaction occurred 
during the preparation of the beads. DSC and XRD studies 
qualitatively confirmed the physical state of the drug 
sodium diclofenacin the beads. The XRD studies revealed 
the absence of crystalline peaks, indicating that the drug 
is well dispersed in the polymeric matrix at the molecular 
level. In vitro release studies revealed that drug release of 
alginate beads can be reduced considerably by treating 
alginate beads with chitosan and that further treatment 
with alginate coating of the different beads prolonged 
the release of Sodium diclofenacto a small extent. It was 
found that the in vitro drug release of all the batches was 
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FIGURE 9 (d) -X-ray diffraction analysis of chitosan.
FIGURE 9 (e) - X-ray diffraction analysis of formulation F2.
best explained by first-order kinetics as these plots showed 
the highest linearity, indicating that the drug release was 
closely dependent on concentration. Drug diffused at a 
comparatively slower rate as the distance for diffusion 
increased, referred to as Higuchi’s kinetics.
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